ENTO

Entero Therapeutics
ENTO

Overview Fund Trends Analyst Outlook Journalist POV

4 hedge funds and large institutions have $817K invested in Entero Therapeutics in 2020 Q1 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
4
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

1
-$82K
2
-$64K
3
-$37K
4
AAP
Ardsley Advisory Partners
Connecticut
-$26K
5
Northern Trust
Northern Trust
Illinois
-$24K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$405K
2
$164K
3
$40K
4
$37K
5
$37K
6
$29K
7
$24K
8
$17K
9
$16K
10
$13K
11
$12K
12
$7K
13
$7K
14
$4K
15
$4K
16
$1K